SEC Form 4 · accession 0001493152-26-034675
Greenwich LifeSciences, Inc. · GLSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Snehal Patel
Officer — CEO and CFO · Director · 10% Owner
Period of report
Jul 23, 2026
Accepted (ET)
Jul 27, 2026 · 6:15 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001799788
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 23, 2026 | P | 2,500 | $13.14 | A | 5,606,602 | D | |
| Common Stock | Jul 24, 2026 | P | 1,100 | $12.88 | A | 5,607,702 | D |
Table II — derivative securities
No Table II lines on this filing.